Table 3.
FA at fiber tract in methamphetamine-dependent and healthy control subjects
Volume of interest | MA group (n = 23) | HC group (n = 18) | Effect size |
---|---|---|---|
Genu corpus callosum | 0.848 ± 0.048* | 0.882 ± 0.041 | −0.74 |
Splenium corpus callosum | 0.879 ± 0.069 | 0.900 ± 0.052 | −0.33 |
Left anterior corona radiata | 0.572 ± 0.060 | 0.597 ± 0.074 | −0.37 |
Right anterior corona radiata | 0.570 ± 0.067 | 0.580 ± 0.085 | −0.13 |
Left midcaudal superior corona radiata | 0.387 ± 0.050* | 0.435 ± 0.075 | −0.75 |
Right midcaudal superior corona radiata | 0.382 ± 0.060* | 0.429 ± 0.058 | −0.77 |
Left caudal superior corona radiata | 0.478 ± 0.067 | 0`506 ± 0.076 | −0.38 |
Right caudal superior corona radiata | 0.482 ± 0.061 | 0.473 ± 0.061 | 0.15 |
Left internal capsule anterior limb | 0.523 ± 0.074 | 0.533 ± 0.071 | −0.13 |
Right internal capsule anterior limb | 0.537 ± 0.065 | 0.522 ± 0.073 | +0.21 |
Left genu internal capsule | 0.617 ± 0.052 | 0.633 ± 0.063 | −0.27 |
Right genu internal capsule | 0.636 ± 0.069 | 0.635 ± 0.065 | +0.01 |
Left internal capsule posterior limb | 0.708 ± 0.040 | 0.707 ± 0.040 | +0.02 |
Right internal capsule posterior limb | 0.721 ± 0.050 | 0.744 ± 0.036 | −0.50 |
Left perforant path | 0.523 ± 0.053 | 0.532 ± 0.069 | −0.14 |
Right perforant path | 0.504 ± 0.04* | 0.543 ± 0.068 | −0.70 |
Data are group means ± standard deviation
FA fractional anisotropy, MA methamphetamine abuser, HC healthy control
*p < 0.05 (protected post hoc one-way ANOVA following omnibus repeated-measures ANOVA)